INTRODUCTIONVitamin D deficiency has been proposed to contribute to the development of various diseases.1 It has been estimated that one billion people worldwide have Vitamin D deficiency. 2 In India more than 90% of apparently healthy Indians have subnormal 25(OH) D levels. [3][4][5][6] The endocrine society suggests that serum levels of 25 [OH] D less than 20 ng/ml as deficiency and levels between 21-29 ng/mL as insufficiency, while levels of 25[OH] D above 30 ng/mL are optimum levels of the vitamin.
7Sunlight is known to be the primary source of vitamin D and its production in the skin depends on exposure to sunshine, latitude, skin-covering clothes, the use of sunscreen lotions and skin pigmentation in healthy individuals. The status of vitamin D depends on the Patients who have received treatment for at least 4 weeks' period (n=38), the improvement (serum 25[OH] D >30 ng/ml) was seen in 84.2% patients (n=32) at the end of 4 weeks itself. There is significant increased (<0.0001) in the physical component scores of the SF-12 QOL questionnaire after 8 weeks of therapy. Conclusions: Nanoparticle based formulation of vitamin D 3 is effective and safe in correction of vitamin D levels in patients with documented deficiency or insufficiency of vitamin D. Also the safety and tolerability is well accepted and reported good to excellent by patients and physician.